Piper Sandler Forecasts Strong Price Appreciation for Procter & Gamble (NYSE:PG) Stock

Procter & Gamble (NYSE:PG) had its price target raised by Piper Sandler from $160.00 to $164.00 in a research report report published on Monday,Benzinga reports. The firm currently has a neutral rating on the stock.

Other research analysts have also recently issued reports about the stock. Citigroup dropped their target price on shares of Procter & Gamble from $200.00 to $181.00 and set a “buy” rating on the stock in a research note on Friday, April 25th. UBS Group reiterated a “buy” rating on shares of Procter & Gamble in a research note on Monday, February 10th. Truist Financial decreased their target price on Procter & Gamble from $185.00 to $180.00 and set a “buy” rating for the company in a research report on Friday, April 25th. Stifel Nicolaus increased their price target on Procter & Gamble from $161.00 to $165.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Finally, JPMorgan Chase & Co. lowered their price objective on Procter & Gamble from $181.00 to $172.00 and set an “overweight” rating on the stock in a research note on Friday, April 11th. Eight analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $178.52.

Procter & Gamble Price Performance

Shares of NYSE PG opened at $159.28 on Monday. The company has a quick ratio of 0.55, a current ratio of 0.76 and a debt-to-equity ratio of 0.50. The company has a market capitalization of $373.44 billion, a PE ratio of 25.36, a PEG ratio of 3.76 and a beta of 0.41. The stock’s 50 day moving average price is $166.56 and its 200-day moving average price is $167.73. Procter & Gamble has a twelve month low of $156.58 and a twelve month high of $180.43.

Procter & Gamble (NYSE:PG) last announced its earnings results on Thursday, April 24th. The company reported $1.54 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.53 by $0.01. The firm had revenue of $19.78 billion during the quarter, compared to analyst estimates of $20.42 billion. Procter & Gamble had a return on equity of 33.00% and a net margin of 18.35%. The business’s revenue was down 2.1% compared to the same quarter last year. During the same period last year, the firm posted $1.52 EPS. On average, equities analysts anticipate that Procter & Gamble will post 6.91 EPS for the current year.

Procter & Gamble Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Monday, April 21st will be given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a yield of 2.65%. This is a boost from Procter & Gamble’s previous quarterly dividend of $1.01. The ex-dividend date of this dividend is Monday, April 21st. Procter & Gamble’s payout ratio is presently 66.98%.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Jennifer L. Davis sold 1,000 shares of Procter & Gamble stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $161.38, for a total transaction of $161,380.00. Following the completion of the sale, the chief executive officer now owns 51,965 shares of the company’s stock, valued at $8,386,111.70. The trade was a 1.89 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Moses Victor Javier Aguilar sold 10,520 shares of the company’s stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $158.67, for a total value of $1,669,208.40. Following the completion of the transaction, the insider now owns 25,182 shares of the company’s stock, valued at $3,995,627.94. The trade was a 29.47 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 64,520 shares of company stock valued at $10,999,268 in the last 90 days. Corporate insiders own 0.18% of the company’s stock.

Institutional Trading of Procter & Gamble

A number of hedge funds have recently bought and sold shares of PG. FAS Wealth Partners Inc. lifted its stake in Procter & Gamble by 2.0% in the fourth quarter. FAS Wealth Partners Inc. now owns 27,690 shares of the company’s stock worth $4,642,000 after purchasing an additional 549 shares during the last quarter. Berkshire Asset Management LLC PA lifted its stake in shares of Procter & Gamble by 0.9% in the 4th quarter. Berkshire Asset Management LLC PA now owns 236,616 shares of the company’s stock valued at $38,833,000 after acquiring an additional 2,179 shares during the last quarter. Strategic Advisors LLC grew its position in Procter & Gamble by 3.4% during the 4th quarter. Strategic Advisors LLC now owns 55,912 shares of the company’s stock worth $9,374,000 after acquiring an additional 1,818 shares during the last quarter. Fortem Financial Group LLC purchased a new position in Procter & Gamble in the 4th quarter worth approximately $569,000. Finally, Richard C. Young & CO. LTD. lifted its position in Procter & Gamble by 2.1% in the fourth quarter. Richard C. Young & CO. LTD. now owns 123,853 shares of the company’s stock valued at $20,764,000 after purchasing an additional 2,568 shares during the last quarter. Institutional investors own 65.77% of the company’s stock.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.